Innate antitumor immune responses, reflected by lymphocytic infiltration of the tumor mass, prior to therapeutic intervention, has been found to positively influence underlying prognosis in HER2‐positive and triple‐negative EBC [26, 27, 28, 29]. This evidence concerns the gene ERBB2 and neoplasm.